What is included with this book?
List of figures and tables | p. xiii |
List of abbreviations | p. xv |
Preface | p. xvii |
About the author | p. xix |
Introduction and epidemiological data | p. 1 |
Data about general epidemiology | p. 1 |
HPV types and their relationship with human diseases | p. 2 |
HPV and its relationship with cancer | p. 5 |
Epidemiology of HPV in men | p. 10 |
Basic virology: structure and nomenclature | p. 15 |
HPV nomenclature | p. 15 |
HPV structure | p. 16 |
Classification: types, subtypes and variants | p. 18 |
Type | p. 19 |
Subtype | p. 20 |
Variants | p. 21 |
Function of viral proteins | p. 21 |
E1 | p. 21 |
E2 | p. 22 |
E4 | p. 22 |
E5 | p. 23 |
E6 | p. 23 |
E7 | p. 23 |
L1 and L2 | p. 23 |
Natural history and transmission: anatomic distribution | p. 27 |
Methods of transmission of HPV infections | p. 28 |
Natural history of HPV infection | p. 29 |
Latent and persistent HPV infections | p. 31 |
Pathogenesis and clinical features | p. 37 |
Pathogenesis | p. 37 |
HPV life cycle | p. 38 |
Interaction of HPV proteins and cell factors | p. 39 |
Immortalization of infected cells | p. 44 |
Clinical features | p. 47 |
Warts | p. 47 |
Epidermodysplasia verruciformis (Lewandowsky-Lutz disease) | p. 49 |
Bowen's disease | p. 50 |
Focal epithelial hyperplasia | p. 50 |
Recurrent respiratory papillomatosis | p. 51 |
The oral cavity | p. 52 |
Malignant diseases | p. 52 |
HPV infection and association with cancer | p. 57 |
The relationship between HPV and cancer | p. 57 |
HPV and cervical cancer | p. 58 |
HPV and other types of anogenital cancers | p. 59 |
HPV and head and neck cancers | p. 61 |
Diagnosis of HPV infection | p. 65 |
Methods of specimen collection | p. 67 |
Conventional and monolayer cytology | p. 69 |
Histopathology | p. 71 |
HPV nucleic acid detection | p. 72 |
DNA hybridization | p. 72 |
Polymerase chain reaction (PCR): type-specific and general primers | p. 73 |
Capture of RNA-DNA hybrids: liquid hybridization | p. 76 |
HPV mRNA detection | p. 79 |
Microarrays (DNA chips) | p. 80 |
Serological assays | p. 80 |
Diagnostic utility of P16INK4a | p. 81 |
Evaluation of DNA testing and HPV mRNA with liquid-based cytology | p. 82 |
Clinical utility of HPV testing | p. 87 |
Screening programmes for cervical cancer diagnosis | p. 87 |
Strategies for the management of HPV infection and risk of cancer | p. 88 |
Treatment | p. 99 |
Treatment of benign lesions | p. 99 |
Treatment of precancerous lesions | p. 103 |
Treatment of cancer | p. 103 |
Prevention: HPV vaccines | p. 107 |
HPV vaccine types | p. 108 |
Composition | p. 108 |
Dose and administration | p. 110 |
Immunogenicity and efficacy | p. 111 |
Safety and adverse events | p. 115 |
Impact on vaccination and cost effectiveness | p. 119 |
Recommendations for the use of HPV vaccines | p. 120 |
Recommendations for routine use | p. 120 |
Vaccination in special populations | p. 122 |
Precautions and contraindications | p. 123 |
HPV vaccine acceptance and licensure status | p. 124 |
Areas for research in HPV vaccines | p. 128 |
Therapeutic vaccines | p. 130 |
The vaccination experience worldwide | p. 133 |
Index | p. 145 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.